Yun Bai is Senior Vice President of CMC at Santa Ana Bio, and responsible for CMC, including development, manufacture and CDMO selection & management. Yun has over 23 years of biotech/pharmaceutical industry experience in biological drug development from early R&D to late-clinical stage. Prior to joining Santa Ana Bio, Yun was Vice President, Head of CMC and global supply chain at 89bio. Prior to 89bio, Yun had held various positions with increasing responsibilities in CMC, global regulatory affairs and supply chain at Mapp Biopharmaceutical, Ambrx, Eli Lilly and Epicyte/Berlex developing a wide variety of protein drug modalities for clinical and commercial applications.

Yun holds a B.S. and M.S. in Chemical/Biochemical Engineering from East China University of Science and Technology, and Ph.D. in Chemical Engineering from Iowa State University.